Thursday, March 30

[CS01] Collaborative Session 01: Innovative diagnostic technologies

Date & Time	March 30 (Thursday), 9:00-10:15	Room 1
Chairs	TBD
Presentations	Single cell sequencing Geoffrey McDermott (10x Genomics, Inc., Korea) Blood disease with AI Tabe Yoko (Juntendo University, Japan) Discover the Unique Power of Using Droplet Digital PCR (ddPCR) for Hematology-Oncology Applications Gina Sun (BioRad, USA) Holotomography and artificial intelligence: label-free 3D imaging, classification, and inference YongKeun Park (Tomocube Inc., Korea)

[SS01] Scientific Session 01: Challenging issues in childhood blood disorders

Date & Time	March 30 (Thursday), 9:00-10:15	Room 2
Chairs	TBD
Presentations	How to diagnosis and treat neutropenia in childhood Kelly Walkovich (University of Michigan, USA) Updates in the treatment of pediatric relapsed/refractory acute myeloid leukemia Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea) CAR T cells and Acute Lymphoblastic Leukemia: Current State, Challenges and Future Approaches Micheal Verneris (University of Colorado School of Medicine, Children’s Hospital Colorado, USA)

[SS02] Scientific Session 02: How far has cell therapy developed in Hodgkin lymphoma?

Date & Time	March 30 (Thursday), 9:00-10:15	Room 3
Chairs	TBD
Presentations	Biological classification of HL by single cell transcriptomics Ralf Küppers (University of Duisburg-Essen, Germany) Emerging Cellular therapy in HL Natalie S Grover (The University of North Carolina at Chapel Hill, USA) Novel treatment of relapsed/refractory Hodgkin lymphoma Hyeon-Seok Eom (National Cancer Center, Korea)

[ES01] Education Session 01: Different treatment goals for overcoming resistance or functional cure in CML

Date & Time	March 30 (Thursday), 9:00-10:15	Room 4
Chairs	TBD
Presentations	Asciminib: the first-in-class allosteric inhibitor of BCR/ABL1 kinase Eun-Ji Choi (University of Ulsan College of Medicine, Korea) Treatment after failure of frontline therapy of CML-CP including allo-HSCT Jieun Uhm (Hanyang University College of Medicine, Korea) Update on Treatment free remission Jae Joon Han (Kyung Hee University College of Medicine, Korea)

[PL01] Plenary Lecture 01

Date & Time	March 30 (Thursday), 10:30-11:15	Room 1
Chair	TBD
Presentation	Regulation of iron metabolism Martina U. Muckenthaler (University of Heidelberg, Germany)

[PS01] Presidential Symposium

Date & Time	March 30 (Thursday), 11:15-12:00	Room 1
Chairs	TBD
Presentation	What can Nano do for Medicine? Taeghwan Hyeon (Seoul National University, Korea)

[JS01] Asian Hematology Session I (JSM & KMMWP) - Multiple Myeloma

Date & Time	March 30 (Thursday), 15:05-16:20	Room 1
Chairs	TBD
Presentations	Clinical researches on POEMS syndrome in Japan Chiaki Nakaseko (International University of Health and Welfare School of Medicine, Japan) Updates on POEMS syndrome in Korea Jin Seok Kim (Yonsei University College of Medicine, Korea) Therapeutic approach of Waldenström's macroglobulinemia in Japan Hiroshi Handa (Gunma University, Japan) Clinical researches on Waldenström's macroglobulinemia in Korea Hosup Lee (Kosin University College of Medicine, Korea)

[SS03] Scientific Session 03: Where we are, in the era of new agents for aplastic anemia?

Date & Time	March 30 (Thursday), 15:05-16:20	Room 2
Chairs	TBD
Presentations	Aplastic Anemia: Current Management Considerations Emma M. Groarke (National Institutes of Health, USA) Clinical and molecular factors of clonal evolution in aplastic anemia Jaroslaw P. Maciejewski (Cleveland Clinic, USA) TBD Jae Wook Lee (The Catholic University of Korea, Korea)

[SS04] Scientific Session 04: How can we approach thrombocytopenia?

Date & Time	March 30 (Thursday), 15:05-16:20	Room 3
Chairs	TBD
Presentations	Diagnosis and treatment of TA-TMA; Current challenge and future strategies Rafael Duarte (Institute Catala d'Oncologia, Barcelona, Spain) Genetics of inherited thrombocytopenia Kathleen Freson (University of Leuven, Belgium) Advances on pathogenesis and diagnosis of TTP Hyun Kyung Kim (Seoul National University College of Medicine, Korea)

[ES02] Education Session 02: How I treat rare lymphomas?

Date & Time	March 30 (Thursday), 15:05-16:20	Room 4
Chairs	TBD
Presentations	Intravascular B-cell lymphoma Youngwoo Jeon (The Catholic University of Korea, Korea) T-large granular lymphocytic leukemia Jae-Cheol Jo (University of Ulsan College of Medicine, Korea) Lymphomatoid granulomatosis Jeong-Ok Lee (Seoul National University Bundang Hospital, Korea)

[CS02] Collaborative Session 02: Innovative therapeutic technologies

Date & Time	March 30 (Thursday), 16:35-17:50	Room 1
Chairs	TBD
Presentations	A Phase 1a Study of BR101801, PI3Kγδ and DNA PK Triple Inhibitor, in Adult Patients with Advanced Hematologic Malignancies Bong-Seog Kim (Boryung Co. Ltd., Korea) BGB-11417 the new Bcl-2 inhibitor, the story so far David Simpson (BeiGene, Ltd., New Zealand) Bispecific antibody : ABL Bio Jonghwa Won (ABL Bio Inc., Korea) T cell-based cellular immunotherapy TBD

[SS05] Scientific Session 05: Artificial intelligence application in hematology

Date & Time	March 30 (Thursday), 16:35-17:50	Room 2
Chairs	TBD
Presentations	Artificial intelligence in hematology: basic concepts Roni Shouval (Memorial Sloan Kettering Cancer Center, USA) How ML deepens our understanding of hematologic malignancies? Valeria Visconte (Cleveland Clinic, USA) Pitfalls of AI for medical application Jongmun Choi (Green Cross Genome, Korea)

[SS06] Scientific Session 06: Definding and improving survival of high-risk multiple myeloma

Date & Time	March 30 (Thursday), 16:35-17:50	Room 3
Chairs	TBD
Presentations	Identification of high-risk multiple myeloma Niels van de Donk (Amsterdam University Medical Center, The Netherlands) Updated diagnosis and treatment of plasma cell leukemia Sung-Hoon Jung (Chonnam National University Hwasun Hospital , Korea) Novel academic BCMA-CART for AL amyloidosis Moshe Gatt (The Hebrew University of Jerusalem, Israel)

[ES03] Education Session 03: Rare hematologic malignancies with cutaneous manifestation

Date & Time	March 30 (Thursday), 16:35-17:50	Room 4
Chairs	TBD
Presentations	Sezary syndrome and Mycosis fungoides Hyewon Lee (National Cancer Center, Korea) Systemic mastocytosis Hyun Jung Lee (Kyung Hee University College of Medicine, Korea) Plasmacytoid dendritic cell neoplasm Yoo Jin Lee (University of Ulsan College of Medicine, Korea)

Friday, March 31

[JS02] ASH-KSH Joint Symposium - T Cell Lymphoma

Date & Time	March 31 (Friday), 9:00-10:15	Room 1
Chairs	TBD
Presentations	Clinical Researchers Conducting NK/T cell lymphoma research TBD Treatment of extranodal NK/T-cell lymphoma: Korean Lymphoma Working Party experience Seok Jin Kim (National Cancer Center, Korea) Clinical Researchers Conducting T-cell lymphoma research TBD Treatment of peripheral T-cell lymphoma: Korean Lymphoma Working Party experience Deok-Hwan Yang (The Catholic University of Korea, Korea)

[SS07] Scientific Session 07: What is the direction of the new CAR-T therapy?

Date & Time	March 31 (Friday), 9:00-10:15	Room 2
Chairs	TBD
Presentations	Clinical factors affecting survival outcomes after CAR-T cell therapy TBD inHouse CAR-T in lymphoma Hyoung Jin Kang (Seoul National University College of Medicine, Korea) Updates on the latest developments in CAR-T therapies Hiroshi Fujiwara (Mie University, Japan)

[SS08] Scientific Session 08: Comprehensive approaches to understand hemophilia

Date & Time	March 31 (Friday), 9:00-10:15	Room 3
Chairs	TBD
Presentations	Genotyping of Hemophilia, Why We Need it and How We Do? Jill Johnsen (University of Washington, USA) Value of National Cohort Registry Data of Hemophilia Jung Woo Han (Yonsei University College of Medicine, Korea) Gene Therapy in Hemophilia: Recent Advances & Updates TBD

[ES04] Education Session 04: Back to the basic: transfusion support

Date & Time	March 31 (Friday), 9:00-10:15	Room 4
Chairs	TBD
Presentations	Transfusion support for HSCT Dong Wook Jekarl (The Catholic University of Korea, Korea) Evidence based transfusion threshold Dae-Hyun Ko (University of Ulsan College of Medicine, Korea) Current status of manufactured blood cells Eun Jung Baek (Hanyang University College of Medicine, Korea)

[PL02] Plenary Lecture 02

Date & Time	March 31 (Friday), 10:30-11:15	Room 1
Chair	TBD
Presentation	The role of the intestinal microbiome in cancer immunotherapy Marcel van den Brink (Memorial Sloan Kettering Cancer Center, USA)

[JS03] International Collaborative Session - Aplastic Anemia

Date & Time	March 31 (Friday), 15:05-16:20	Room 1
Chairs	TBD
Presentations	Overview of AA diagnosis and treatment in NIHBT, VietNam Nguyen Thi Thao (National Institute of Hematology and Blood Transfusion, Vietnam) The Incidence and Real-world Outcome of Aplastic Anemia in Thailand Lalita Norasetthada (Maharaj Nakorn Chiengmai , Thailand) Role of TPO receptor agonists in aplastic anemia treatment Jun Ho Jang (Samsung Medical Center, Korea)

[SS09] Scientific Session 09: Which immune therapy is our future weapon against AML?

Date & Time	March 31 (Friday), 15:05-16:20	Room 2
Chairs	TBD
Presentations	DART therapy for AML Sergio Rutella (John van Geest Cancer Research Centre, UK) Determining the barriers to successful CAR T cell therapy for AML Miriam Y Kim (University of Washington, USA) Adoptive T cell transfer of three universal tumor associated antigens-specific T cells for the treatment of AML Byung Sik Cho (The Catholic University of Korea, Korea)

[SS10] Scientific Session 10: Advanced technologies in cytogenetics and molecular genetics

Date & Time	March 31 (Friday), 15:05-16:20	Room 3
Chairs	TBD
Presentations	Whole-transcriptome analysis in ALL TBD Whole genome sequencing of fluorescence in situ hybridized cells in hematologic malignancies using SLACS Sunghoon Kwon (Seoul National University, Korea) Next generation cytogenetics – optical mapping for comprehensive structural variant detection in hematological malignancies and beyond Alexander Hoischen (Chonnam National University Medical School, Korea)

[ES05] Education Session 05: Practical issue in CAR-T

Date & Time	March 31 (Friday), 15:05-16:20	Room 4
Chairs	TBD
Presentations	Setting up the facility for CAR T cell therapy Ja Min Byun (Seoul National University College of Medicine, Korea) Technical aspect of manufacturing CAR T cell product Jong-Seo Lee (AbClon Inc., Korea) Managing adverse events of CAR T cell therapy Jae Won Yoo (The Catholic University of Korea, Korea)

[JS04] EHA-KSH Joint Symposium - Myelodysplastic Syndrome

Date & Time	March 31 (Friday), 16:35-17:50	Room 1
Chairs	TBD
Presentations	MDS 2023: standards and perspectives Uwe Platzbecker (Leipzig University Hospital, Germany) Treatment of MDS: Korean AML/MDS working party experience June-Won Cheong (Yonsei University College of Medicine, Korea) TBD Lionel Adès (Co-chair of the SWG MDS, France) Genetic alteration in MDS Yoo-Jin Kim (The Catholic University of Korea, Korea)

[SS11] Scientific Session 11: Liquid biopsy application in hematology

Date & Time	March 31 (Friday), 16:35-17:50	Room 2
Chairs	TBD
Presentations	Cell-free DNA profiling for monitoring of complications of hematopoietic cell transplantation Iwijn De Vlaminck (Cornell University, USA) Microbial cell-free DNA sequencing to predict bloodstream infection in pediatric cancer patients Charles Gawad (St. Jude Children's Research Hospital, USA) Clinical applications of circulating tumor DNA analysis in lymphoma Seung-Tae Lee (Yonsei University College of Medicine, Korea)

[SS12] Scientific Session 12: Up-to-date diagnostic and treatment strategies of adult ALL patients

Date & Time	March 31 (Friday), 16:35-17:50	Room 3
Chairs	TBD
Presentations	Are we moving towards a chemo- and transplant-free management of Ph-positive adult ALL? Robin Foa (Sapienza University of Rome, Italy) Development of more-effective CAR T-cell therapy for ALL Saar I Gill (University of Pennsylvania School of Medicine, USA) Overcoming high-risk features in adult ALL patients Jae-Ho Yoon (The Catholic University of Korea, Korea)

Saturday, April 1

[JS05] Asian Hematology Session II - Red Blood Cell Disorder

Date & Time	April 1 (Saturday), 9:00-10:15	Room 1
Chairs	TBD
Presentations	Overview of Thalassaemia and Hemoglobinopathies in Bangladesh Mahmood A. Chowdhury (Chattogram Maa-O-Shishu Hospital Medical College, Bangladesh) Current Situation of Thalassemia Care in Cambodia Chean Sophal (National Pediatric Hospital, Cambodia) Epidemiology and diagnosis of hemolytic anemia in Korea Heewon Chueh (Dong-A University College of Medicine, Korea)

[SS13] Scientific Session 13: Current knowledge of human hematopoietic stem cell

Date & Time	April 1 (Saturday), 9:00-10:15	Room 2
Chairs	TBD/td>
Presentations	Single cell HSPC map William J. Greenleaf (Stanford University, USA) Humanized Mouse and Non-human Primates: Animal Models for HSC Research Kyung-Rok Yu (Seoul National University, Korea) What we know about HSC homing? Xinxin Huang (Fudan University, China)

[SS14] Scientific Session 14: What's new in chronic lymphocytic leukemia?

Date & Time	April 1 (Saturday), 9:00-10:15	Room 3
Chairs	TBD
Presentations	Patient selection for time limited versus continued therapy Jennifer R. Brown (Dana-Farber Cancer Institute, USA) Translating scientific advances in CLL Richard Rosenquist (Karolinska Institute, Sweden) MRD monitoring in CLL Patients Ki-Seong Eom (The Catholic University of Korea, Korea)

[ES06] Education Session 06: Novel therapeutics for myeloproliferative neoplasms

Date & Time	April 1 (Saturday), 9:00-10:15	Room 4
Chairs	TBD
Presentations	Prognostication in MPNs (including mutation abnormalities) Junshik Hong (Seoul National University Hospital, Korea) Novel Therapeutics for MF (including cyotpenic myelofibrosis) Sung-Eun Lee (The Catholic University of Korea, Korea) Novel Therapeutics for ET/PV Seugyun Yoon (Soonchunhyang University Seoul Hospital, Korea)

[PL03] Plenary Lecture 03

Date & Time	April 1 (Saturday), 10:30-11:15	Room 1
Chairs	TBD
Presentation	Recent advance in the hematopoietic stem cell research Toshio Suda (National University of Singapore, Singapore)